These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 1300554)

  • 21. [Evaluation on usage of serum troponin-I, CK-MBmass and myoglobin measurements in diagnosing acute myocardial infarction].
    Wang L; Wu Y; Li L
    Hua Xi Yi Ke Da Xue Xue Bao; 2000 Jun; 31(2):239-41, 245. PubMed ID: 12515148
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Value of mass dosage of the MB isoenzyme of creatinine phosphokinase in the diagnosis of recent myocardial infarction].
    Grand A; Fournis Y; Siramy M; Ghadban W; Douieb A; Daboura A; Jaidane H; Fichter P; Huret JF; Hellio D
    Arch Mal Coeur Vaiss; 1997 Jun; 90(6):807-15. PubMed ID: 9295933
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Usefulness of a rapid initial increase in plasma creatine kinase activity as a marker of reperfusion during thrombolytic therapy for acute myocardial infarction.
    Lewis BS; Ganz W; Laramee P; Cercek B; Hod H; Shah PK; Lew AS
    Am J Cardiol; 1988 Jul; 62(1):20-4. PubMed ID: 3381752
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Predisposing factors and prognostic value of sustained monomorphic ventricular tachycardia in the early phase of acute myocardial infarction.
    Mont L; Cinca J; Blanch P; Blanco J; Figueras J; Brotons C; Soler-Soler J
    J Am Coll Cardiol; 1996 Dec; 28(7):1670-6. PubMed ID: 8962550
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A score predicts failure of reperfusion after fibrinolytic therapy for acute myocardial infarction.
    French JK; Ramanathan K; Stewart JT; Gao W; Théroux P; White HD
    Am Heart J; 2003 Mar; 145(3):508-14. PubMed ID: 12660675
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Changes on release of MB isoenzyme of creatine kinase by propranolol in acute myocardial infarction (author's transl)].
    Rolli A; Favaro L; Aurier E; Tagliavini S; Ciarlini E; Brizzi MP; Botti G
    G Ital Cardiol; 1980; 10(4):444-51. PubMed ID: 7002691
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Electrocardiography and serum CK-MB determination in myocardial infarction and reperfusion in patients treated with intravenous streptokinase or placebo].
    Clemmensen PM; Grande P; Saunamäki K; Granborg J; Svendsen JH; Pedersen F; Haedersdal C; Madsen JK; Wagner GS
    Ugeskr Laeger; 1993 Jan; 155(1):36-40. PubMed ID: 8421847
    [No Abstract]   [Full Text] [Related]  

  • 28. Human heart-type cytoplasmic fatty acid-binding protein (H-FABP) for the diagnosis of acute myocardial infarction. Clinical evaluation of H-FABP in comparison with myoglobin and creatine kinase isoenzyme MB.
    Okamoto F; Sohmiya K; Ohkaru Y; Kawamura K; Asayama K; Kimura H; Nishimura S; Ishii H; Sunahara N; Tanaka T
    Clin Chem Lab Med; 2000 Mar; 38(3):231-8. PubMed ID: 10905760
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Performance characteristics of creatine kinase-MB isoenzyme measured with an immunoenzymometric and an immunoinhibition assay in acute myocardial infarction with and without thrombolytic therapy.
    Schiøler V; Thode J; Kjøller E
    Eur J Clin Chem Clin Biochem; 1992 Jun; 30(6):357-61. PubMed ID: 1511070
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Plasma CK-MB activity and QRS score in estimating acute myocardial infarct size].
    Luo ZM; Zhang GY; Chong KM
    Zhonghua Xin Xue Guan Bing Za Zhi; 1989 Oct; 17(5):279-82, 318. PubMed ID: 2636124
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Early peak activity of creatine kinase in non-thrombolysed myocardial infarction: prognostic factor?].
    Legeais S; Louvard Y
    Arch Mal Coeur Vaiss; 1988 Nov; 81(11):1345-52. PubMed ID: 3147626
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Study on the clinical value of serum cardiac troponin T in early diagnosing of acute non-Q-wave myocardial infarction and prognostic evaluation].
    Zheng Q; Wang WZ; Zhang YX; Wang L; Zhao LJ
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2004 Mar; 16(3):179-81. PubMed ID: 15009972
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Evaluation of the kinetics of MB creatine kinase in patients undergoing systemic thrombolytic therapy].
    Arrigo F; Saccà CM; Cavalli A; Egitto M; Barillari M; Costa G; Cavalli G; Carerj S; Melluso C
    Cardiologia; 1991 Nov; 36(11):861-6. PubMed ID: 1817758
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Reduction of CK and CK-MB enzyme levels as indicators of infarct size by intravenous nitroglycerin (author's transl)].
    Bussmann WD; Passek D; Seidel W; Klepzig H; Kaltenbach M
    Z Kardiol; 1980 Jan; 69(1):18-30. PubMed ID: 6774493
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Limiting the area of myocardial necrosis and ischemia by intravenous infusion of nitroglycerin and streptokinase in the early stage of myocardial infarction evaluated by multifocal electrocardiography and release of the CK-MB isoenzyme].
    Szczepańczyk E; Gdyra D; Kuch J
    Wiad Lek; 1985 Dec; 38(23):1625-31. PubMed ID: 3938584
    [No Abstract]   [Full Text] [Related]  

  • 36. Reduction of CK and CK-MB indexes of infarct size by intravenous nitroglycerin.
    Bussmann WD; Passek D; Seidel W; Kaltenbach M
    Circulation; 1981 Mar; 63(3):615-22. PubMed ID: 6780232
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prodromal unstable angina in acute myocardial infarction: prognostic value of short- and long-term outcome and predictor of infarct size.
    Bahr RD; Leino EV; Christenson RH
    Am Heart J; 2000 Jul; 140(1):126-33. PubMed ID: 10874273
    [TBL] [Abstract][Full Text] [Related]  

  • 38. ECG and enzymatic indicators of therapeutic success after intravenous streptokinase for acute myocardial infarction.
    Clemmensen P; Grande P; Pedersen F; Granborg J; Svendsen JH; Madsen JK; Haedersdal C; Saunamäki K
    Am Heart J; 1990 Sep; 120(3):503-9. PubMed ID: 2389686
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Kinetics of serum creatine kinase and creatine kinase-MB after intracoronary thrombolysis.
    Bartelsen FM; Rehpenning W; Harm K; Runge M; Mathey DG
    Klin Wochenschr; 1985 Jun; 63(11):499-504. PubMed ID: 4010222
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic implications of creatine kinase-MB measurements in ST-segment elevation myocardial infarction patients treated with primary percutaneous coronary intervention.
    Bagai A; Schulte PJ; Granger CB; Mahaffey KW; Christenson RH; Bell G; Lopes RD; Green CL; Lincoff AM; Armstrong PW; Roe MT
    Am Heart J; 2014 Oct; 168(4):503-511.e2. PubMed ID: 25262260
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.